Ovarian Primordial Follicle Development
Ovarian Primordial Follicle Development
批准号:
7388875
负责人:
MICHAEL K SKINNER
金额:
$22.9万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-05-05 至 2011-02-28
关键词:
AgonistApoptosisCell CommunicationCellsConditionDevelopmentDiagnostic ProcedureDiseaseEstrogensEventFeedbackFemaleFemale infertilityFertilityFibroblast Growth FactorFibroblast Growth Factor 2Functional disorderFutureGrowth FactorHormonalHormonesIn VitroKnock-outLaboratory cultureMaintenanceMediatingMenopauseMolecularMutant Strains MiceMutationOocytesOrgan Culture TechniquesOvarianPhysiologicalPlayPremature Ovarian FailurePrimordial FollicleProcessProductionProgesteronePubertyPublic HealthRecruitment ActivityRegulationReproductionResearchResearch PersonnelRoleSomatic CellStagingStem Cell FactorSteroidsTestingTherapeuticTransgenic Organismsbone morphogenic proteindesignfolliculogenesisgranulosa cellhuman diseasein vivoinsightinterestkeratinocyte growth factorleukemia inhibitory factormouse modelparacrinepreventprogramsreceptorresearch studysteroid hormonetheca cell
中文摘要
点击翻译按钮获取中文摘要
英文摘要
OVARIAN PRIMORDIAL FOLLICLE DEVELOPMENT
The proposed research is directed toward developing a better understanding of the mechanisms that control
primordial follicle development. This process is essential for the establishment and maintenance of female
reproduction. Primordial follicle development involves the initial event of primordial follicle assembly and the
subsequent event of primordial to primary follicle transition. The process involved in primordial follicle
assembly is distinct from that of primordial to primary follicle transition and both will be investigated in the
proposed research. The manner by which locally produced ovarian substances and hormones regulate
these processes are of particular interest. Previous research and preliminary studies have demonstrated
that the control of primordial follicle development and subsequent folliculogenesis appears to be mediated by
the local production and action of specific paracrine factors involving theca cells, granulosa cells, and the
oocyte. Preliminary studies have shown that steroid hormones (i.e. estrogen and progesterone) play a
critical role in the onset of primordial follicle assembly. Preliminary studies also demonstrate that primordial
to primary follicle transition requires integrated interactions between the oocyte, granulosa cells and
precursor theca cells involving kit ligand (KL),basic fibroblast growth factor (bFGF), leukemia inhibitory
factor (LIF), keratinocyte growth factor (KGF) and bone morphogenic protein-4 (BMP4). "THE GENERAL
HYPOTHESIS TESTED IS THAT HORMONES INFLUENCE THE PARACRINE GROWTH FACTOR
MEDIATED INTERACTIONS BETWEEN THE OVARIAN SOMATIC CELLS AND THE OOCYTE TO
CONTROL PRIMORDIAL FOLLICLE ASSEMBLY AND DEVELOPMENT". Interactions between hormones
and paracrine growth factors provide an efficient mechanism to control primordial follicle development. It is
anticipated that abnormalities in these cellular interactions will influence female fertility, menopause onset
and promote pathophysiologies such as premature ovarian failure. The experimental approach consists of
the following specific aims: 1) Elucidate the hormonal and paracrine growth factor control of primordial follicle
assembly. 2) Elucidate the hormonal and growth factor control of the primordial to primary follicle transition.
3) Elucidate the physiological importance of specific factors that mediate primordial follicle development.
Completion of these specific aims will extend previous observations and provide insight into the role of
growth factor mediated cell-cell interactions in regulating primordial follicle development. The critical
developmental periods to be examined include the induction of primordial follicle assembly and the
primordial to primary follicle transition. It is anticipated that the specific cell-cell interactions will change
between these developmental periods. The differential effects of hormones on growth factors and relevant
receptors have a critical role in later stages of follicle development, but remain to be determined in primordial
follicle development. Observations are anticipated to provide insight into the molecular and cellular control of
primordial follicle development.
PUBLIC HEALTH RELEVANCE: The information obtained will be used to understand the onset of puberty
and menopause, as well as provide insight into the potential future design of diagnostic procedures and
therapeutic treatments for abnormal ovarian conditions such as premature ovarian failure (POF) and forms of
female infertility. An example of a future experiment proposed is to determine if mutation(s) exist in any of
the repertoire of growth factors and/or receptors established in the current study as potential causal factors
for disease states such as premature ovarian failure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2009 Mammalian Gametogenesis
-
批准号:7672650
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2009
-
负责人:MICHAEL K SKINNER
-
依托单位:
Ovarian Primordial Follicle Development
-
批准号:7570040
-
项目类别:
-
资助金额:$22.89万
-
财政年份:2006
-
负责人:MICHAEL K SKINNER
-
依托单位:
Ovarian Primordial Follicle Development
-
批准号:7102937
-
项目类别:
-
资助金额:$24.1万
-
财政年份:2006
-
负责人:MICHAEL K SKINNER
-
依托单位:
Ovarian Primordial Follicle Development
-
批准号:7228856
-
项目类别:
-
资助金额:$23.38万
-
财政年份:2006
-
负责人:MICHAEL K SKINNER
-
依托单位:
Ovarian Primordial Follicle Development
-
批准号:7774397
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2006
-
负责人:MICHAEL K SKINNER
-
依托单位:
Epigenetic Transgenerational Endocrine Disruptor Actions
-
批准号:8696510
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2005
-
负责人:MICHAEL K SKINNER
-
依托单位:
EPIGENETIC TRANSGENERATIONAL ENDOCRINE DISRUPTOR ACTIONS
-
批准号:7434209
-
项目类别:
-
资助金额:$0.84万
-
财政年份:2005
-
负责人:MICHAEL K SKINNER
-
依托单位:
Epigenetic Transgenerational Endocrine Disruptor Actions
-
批准号:9247187
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2005
-
负责人:MICHAEL K SKINNER
-
依托单位:
Epigenetic Transgenerational Endocrine Disruptor Actions
-
批准号:8845554
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2005
-
负责人:MICHAEL K SKINNER
-
依托单位:
Epigenetic Transgenerational Endocrine Disruptor Actions
-
批准号:8461236
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2005
-
负责人:MICHAEL K SKINNER
-
依托单位:
Epigenetic Transgenerational Endocrine Disruptor Actions
-
批准号:8711922
-
项目类别:
-
资助金额:$9.06万
-
财政年份:2005
-
负责人:MICHAEL K SKINNER
-
依托单位:
EPIGENETIC TRANSGENERATIONAL ENDOCRINE DISRUPTOR ACTIONS
-
批准号:6998882
-
项目类别:
-
资助金额:$23.83万
-
财政年份:2005
-
负责人:MICHAEL K SKINNER
-
依托单位:
EPIGENETIC TRANSGENERATIONAL ENDOCRINE DISRUPTOR ACTIONS
-
批准号:7322115
-
项目类别:
-
资助金额:$22.68万
-
财政年份:2005
-
负责人:MICHAEL K SKINNER
-
依托单位:
Epigenetic Transgenerational Endocrine Disruptor Actions
-
批准号:8068371
-
项目类别:
-
资助金额:$36.2万
-
财政年份:2005
-
负责人:MICHAEL K SKINNER
-
依托单位:
EPIGENETIC TRANSGENERATIONAL ENDOCRINE DISRUPTOR ACTIONS
-
批准号:6873309
-
项目类别:
-
资助金额:$24.41万
-
财政年份:2005
-
负责人:MICHAEL K SKINNER
-
依托单位:
Epigenetic Transgenerational Endocrine Disruptor Actions
-
批准号:8272620
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2005
-
负责人:MICHAEL K SKINNER
-
依托单位:
EPIGENETIC TRANSGENERATIONAL ENDOCRINE DISRUPTOR ACTIONS
-
批准号:7215350
-
项目类别:
-
资助金额:$4.3万
-
财政年份:2005
-
负责人:MICHAEL K SKINNER
-
依托单位:
EPIGENETIC TRANSGENERATIONAL ENDOCRINE DISRUPTOR ACTIONS
-
批准号:7152839
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2005
-
负责人:MICHAEL K SKINNER
-
依托单位:
Epigenetic Transgenerational Endocrine Disruptor Actions
-
批准号:7730534
-
项目类别:
-
资助金额:$39.66万
-
财政年份:2005
-
负责人:MICHAEL K SKINNER
-
依托单位:
Epigenetic Transgenerational Endocrine Disruptor Actions
-
批准号:7878089
-
项目类别:
-
资助金额:$37.85万
-
财政年份:2005
-
负责人:MICHAEL K SKINNER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: